- Featured Product
- KD/KO Validated
SETD7 Polyclonal antibody
SETD7 Polyclonal Antibody for IF, WB, ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
WB, IHC, IF, CoIP, ELISA
Conjugate
Unconjugated
Cat no : 24840-1-AP
Synonyms
Validation Data Gallery
Tested Applications
| Positive WB detected in | HeLa cells, C6 cells, mouse brain tissue, mouse kidney tissue, NIH/3T3 cells, rat brain tissue |
| Positive IF detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:5000 |
| Immunofluorescence (IF) | IF : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Published Applications
| KD/KO | See 1 publications below |
| WB | See 4 publications below |
| IHC | See 1 publications below |
| CoIP | See 2 publications below |
Product Information
24840-1-AP targets SETD7 in WB, IHC, IF, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen | SETD7 fusion protein Ag18219 |
| Full Name | SET domain containing (lysine methyltransferase) 7 |
| Calculated Molecular Weight | 366 aa, 41 kDa |
| Observed Molecular Weight | 48-50 kDa |
| GenBank Accession Number | BC121055 |
| Gene Symbol | SETD7 |
| Gene ID (NCBI) | 80854 |
| RRID | AB_2737406 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
SET domain containing lysine methyltransferase 7 (SETD7, also called SET7/9) was the first lysine methyltransferase (KMT) discovered to specifically monomethylate lysine-4 of histone 3 (H3K4me1) (PMID: 26435321). SETD7 has been shown to have a very broad target specificity in vitro, including transcriptional regulators such as TAF10, p53, ER, p65, STAT3, Rb, Mypt, Tat, and Foxo3 (PMID: 25136132, 30013796).
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for SETD7 antibody 24840-1-AP | Download protocol |
| IF protocol for SETD7 antibody 24840-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
EBioMedicine Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients. | ||
Oncotarget SETD7 is a prognosis predicting factor of breast cancer and regulates redox homeostasis.
| ||
FASEB J SETD7 mediates the vascular invasion in articular cartilage and chondrocytes apoptosis in osteoarthriis. | ||
Exp Cell Res Proteomic analysis of DZIP3 interactome and its role in proliferation and metastasis in gastric cancer cells | ||
Med Oncol DDB1 regulates the activation-induced apoptosis of T cells via downregulating the expression of histone methyltransferase SETD7 | ||
Histol Histopathol ZKSCAN5 activates LAPTM5 expression by recruiting SETD7 to promote metastasis in pancreatic ductal adenocarcinoma |
